Concurrent Investment Advisors LLC Takes Position in Agilent Technologies, Inc. $A

Key Points

• Concurrent Investment Advisors LLC has acquired a new stake in Agilent Technologies, purchasing 2,260 shares valued at about $267,000.
• The company recently reported earnings per share of $1.37 for the last quarter, meeting analysts' expectations, while revenue increased by 10.1% year-over-year to $1.74 billion.
• Agilent Technologies has announced a quarterly dividend of $0.248 per share, with an annualized yield of 0.7%, reflecting a payout ratio of 23.24%.

Concurrent Investment Advisors LLC bought a new stake in Agilent Technologies, Inc. (NYSE:A - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 2,260 shares of the medical research company's stock, valued at approximately $267,000.

Other hedge funds have also made changes to their positions in the company. Stone House Investment Management LLC purchased a new position in shares of Agilent Technologies in the 1st quarter valued at $30,000. Ransom Advisory Ltd purchased a new position in shares of Agilent Technologies in the 1st quarter valued at $32,000. Central Pacific Bank Trust Division purchased a new position in shares of Agilent Technologies in the 2nd quarter valued at $33,000. Zions Bancorporation National Association UT purchased a new position in shares of Agilent Technologies in the 1st quarter valued at $38,000. Finally, Costello Asset Management INC purchased a new position in shares of Agilent Technologies in the 1st quarter valued at $47,000.

Agilent Technologies Price Performance

A opened at $142.01 on Monday. The company has a 50-day moving average of $127.58 and a 200-day moving average of $117.90. The company has a market capitalization of $40.26 billion, a P/E ratio of 33.34, a PEG ratio of 4.63 and a beta of 1.26. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $153.84. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25.

Agilent Technologies (NYSE:A - Get Free Report) last released its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting the consensus estimate of $1.37. The company had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company's revenue was up 10.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Equities analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be given a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $0.99 annualized dividend and a dividend yield of 0.7%. Agilent Technologies's payout ratio is presently 23.24%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on A shares. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Agilent Technologies in a research note on Wednesday, October 8th. Rothschild Redb raised shares of Agilent Technologies to a "strong-buy" rating in a research note on Wednesday, October 8th. Wall Street Zen raised shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Friday, October 3rd. Barclays lifted their price target on shares of Agilent Technologies from $125.00 to $150.00 and gave the stock an "equal weight" rating in a research note on Thursday, October 2nd. Finally, UBS Group raised shares of Agilent Technologies from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $130.00 to $170.00 in a research note on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have given a Hold rating to the company's stock. According to data from MarketBeat, Agilent Technologies has an average rating of "Moderate Buy" and a consensus price target of $149.62.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.